Abstract
Bupivacaine and levobupivacaine are amino amide local anesthetics commonly used in medical practice. Although bupivacaine consists of a racemic mixture of S (–)-bupivacaine and R (+)-bupivacaine enantiomers, levobupivacaine is comprised of pure S (–)-bupivacaine. It has been known that levobupivacaine is preferable to bupivacaine since it may cause cardiovascular and nervous system toxicity. For determining genotoxicity of these anesthetics, we used the wing somatic mutation and recombination test in Drosophila melanogaster. Three-day-old trans-heterozygous larvae were treated with bupivacaine and levobupivacaine. Analysis of the standard crosses indicated that bupivacaine and levobupivacaine did not exhibit mutagenic or recombinogenic activity until toxic doses have been reached at the larval stage. When we examined bupivacaine and levobupivacaine in the HB cross, bupivacaine did not exhibit any genotoxicity at high concentrations (500 µg/mL), but levobupivacaine did exert genotoxicity at high concentrations (1000 µg/mL)—depending on the substantial recombinogenic effect.
Similar content being viewed by others
References
Af Ekenstam B, Egner B, Pettersson G (1957) Local anaesthetics: i. N-alkyl pyrrolidine and N-alkyl piperidine carboxylic acid amides. Acta Chem Scand 11:1183–1190
Albright GA (1979) Cardiac arrest following regional anesthesia with etidocaine or bupivacaine. Anesthesiology 51:285–287
Barile F (2008) Principles of toxicology testing. CRC Press, Boca Raton
Bishop AJ, Schiestl RH (2003) Role of homologous recombination in carcinogenesis. Exp Mol Pathol 74:94–105
Burlacu CL, Buggy DJ (2008) Update on local anesthetics: focus on levobupivacaine. Ther Clin Risk Manag 4:381–392
Chalkiadis GA, Anderson BJ, Tay M, Bjorksten A, Kelly JJ (2005) Pharmacokinetics of levobupivacaine aftercaudalepiduraladministration in infantslessthan 3 months of age. Br J Anaesth 95:524–529
Dapkus D, Merrell DJ (1977) Chromosomal analysis of DDT resistance in a long-term selected population of Drosophila melanogaster. Genetics 87:685–697
Drasner K (2011) Local Anesthetics. In: Miller RD, Pardo MC Jr (eds) Basics of Anesthesia. Elsevier, Philadelphia, pp 130–142
Frei H, Würgler FE (1988) Statistical methods to decide whether mutagenicity test data from Drosophila assays indicate a positive, negative or inconclusive result. Mutat Res 203:297–308
Frei H, Würgler FE (1996) Induction of somatic mutation and recombination by four inhibitors of eukaryotic topoisomerases assayed in the wing spot test of Drosophila melanogaster. Mutagenesis 11:315–325
Frei H, clements J, Howe D, Würgler FE (1992) The genotoxicity of the anti-cancer drug mitoxantrone in somatic and germ cells of Drosophila melanogaster. Mutat Res 279:21–33
Gantenbein M, Attolini L, Bruguerolle B, Villard PH, Puyoou F, Durand A, Lacarelle B, Hardwisgen J, Le-Treut YP (2000) Oxidative metabolism of bupivacaine into pipecolylxylidine in humans is mainly catalyzed by CYP3A. Drug Metab Dispos 28:383–385
Graf U, Singer D (1992) Genotoxicity testing of promutagens in the wing somatic mutation and recombination test in Drosophila melanogaster. Rev Int Contam Ambient 8:15–27
Graf U, van Schaik N (1992) Improved high bioactivation cross for the wing mutation and recombination test in Drosophila melanogaster. Mutat Res 271:59–67
Graf U, Würgler FE, Katz AJ, Frei H, Juon H, Hall CB, Kale PG (1984) Somatic mutation test in Drosophila melanogaster. Environ Mutagen 6:153–188
Graf U, van Schaik N, Pacella R (1991) Improved “High Bioactivation” cross for the SMART wing assay. Drosoph Inf Serv 70:247–248
Graf U, Abraham SK, Guzmán-Rincón J, Würgler FE (1998) Antigenotoxicity studies in Drosophila melanogaster. Mut Res 402:203–209
Gürbüzel M, Oral E, Kizilet H, Halici Z, Gulec M (2012) Genotoxic evaluation of selective serotonin-reuptake inhibitors by use of the somatic mutation and recombination test in Drosophila melanogaster. Mutat Res 748:17–20
Gürbüzel M, Capoğlu I, Kızılet H, Halıcı Z, Ozçiçek F, Demirtaş L (2014) Genotoxic evaluation of two oral antidiabetic agents in the Drosophila wing spot test. Toxicol Ind Health 30:376–383
Guzmán Rincón J, Graf U (1995) Drosophila melanogaster somatic mutation and recombination test as a biomonitor. In: Butterworth FM, Corkum LD, Guzmán Rincón J (eds) Biomonitors and biomarkers as indicators of environmental change. Plenum Press, New York, pp 169–181
Hagiwara M, Watanabe E, Barrett JC, Tsutsui T (2006) Assessment of genotoxicity of 14 chemical agents used in dental practice: ability to induce chromosome aberrations in Syrian hamster embryo cells. Mutat Res 603:111–120
Hällström I, Blanck A, Atuma S (1984) Genetic variation in cytochrome P-450 and xenobiotic metabolism in Drosophila melanogaster. Biochem Pharmacol 33:13–20
Huang YF, Pryor ME, Mather LE, Veering BT (1998) Cardiovascular and central nervous system effects of intravenous levobupivacaine and bupivacaine in sheep. Anesth Analg 86:797–804
Idaomar M, El Hamss R, Bakkali F, Mezzoug N, Zhiri A, Baudoux D, Muñoz-Serrano A, Liemans V, Alonso-Moraga A (2002) Genotoxicity and antigenotoxicity of some essential oils evaluated by wing spot test of Drosophila melanogaster. Mutat Res 513:61–68
Karadeniz A, Kaya B, Savaş B, Topcuoğlu ŞF (2011) Effects of two plant growth regulators, indole-3-acetic acid and β-naphthoxyacetic acid, on genotoxicity in Drosophila SMART assay and on proliferation and viability of HEK293 cells from the perspective of carcinogenesis. Toxicol Ind Health 27:840–848
Kastenbaum MA, Bowman KO (1970) Tables for determining the statistical significance of mutation frequencies. Mutat Res 9:527–549
Kaya B, Marcos R, Yanikoğlu A, Creus A (2004) Evaluation of the genotoxicity of four herbicides in the wing spot test of Drosophila melanogaster using two different strains. Mutat Res 557:53–62
Kayukawa E, Kikuchi S, Tsutsui T (1988) Cytotoxicity, genotoxicity and carcinogenicity of local anesthetics to cultured Syrian hamster embryo cells. Shiqaku 76:941–962
Koksal PM, Gürbüzel M (2015) Analysis of genotoxic activity of ketamine and rocuronium bromide using the somatic mutation and recombination test in Drosophila melanogaster. Environ Toxicol Pharmacol 39:628–634
Kulbacka J, Bar J, Chwilkowska A, Dumanska M, Drag-Zalesinska M, Wysocka T, Stach K, Bednarz I, Lugowski M, Marcinkowska A, Gamian A, Saczko J (2009) Oxidative modulation of Marcaine and lekoptin in H9C2 rat myoblasts. Acta Pharmacol Sin 30:184–192
Leone S, Di Cianni S, Casati A, Fanelli G (2008) Pharmacology, toxicology, and clinical use of new long acting local anesthetics, ropivacaine and levobupivacaine. Acta Biomed 79:92–105
Leuschner J, Leblanc D (1999) Studies on the toxicological profile of the local anaesthetic articaine. Arzneimittelforschung 49:126–132
Lindsley DL, Zimm GG (1992) The genome of Drosophila melanogaster. Academic Press, San Diego
Mendola C, Ferrante D, Oldani E, Cammarota G, Cecci G, Vaschetto R, Della Corte F (2009) Thoracic epidural analgesia in post-thoracotomy patients: comparison of three different concentrations of levobupivacaine and sufentanil. Br J Anaesth 102:418–423
Nai GA, de Oliveira MC, de Oliveira TG, Pereira LF, Soares ND, Silva PG (2015) Evaluation of genotoxicity induced by repetitive administration of local anaesthetics: an experimental study in rats. Braz J Anesthesiol 65:21–26
Osaba L, Aguirre A, Alonso A, Graf U (1999) Genotoxicity testing of six insecticides in two crosses of the Drosophila wing spot test. Mutat Res 439:49–61
Pacella RE (1993) Genotoxicity of mycotoxins in an improved Drosophila wing spot test and other short-term tests, PhD thesis. Witwatersrand University, Johannesburg
Pacella RE, van Schaik N, Graf U (1996) New “high bioactivation” cross for the SMART wing assay. Drosoph Inf Serv 77:152–153
Schneider LE, do Amaral VS, Dihl RR, Lehmann M, Reguly ML, de Andrade HHR (2009) Assessment of genotoxicity of Lidocaine®, Prilonest® and Septanest® in the Drosophila wing-spot test. Food Chem Toxicol 47:205–208
Scott DB, Lee A, Fagan D, Bowler GM, Bloomfield P, Lundh R (1989) Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg 69:563–569
Spanó MA, Frei H, Würgler FE, Graf U (2001) Recombinagenic activity of four compounds in the standard and high bioactivation crosses of Drosophila melanogaster in the wing spot test. Mutagenesis 16:385–394
Tijet N, Helvig C, Feyereisen R (2001) The cytochrome P450 gene superfamily in Drosophila melanogaster: annotation, intron-exon organization and phylogeny. Gene 262:189–198
Acknowledgments
This research was partially supported by a grant from the Research Fund of Erzincan, University (Project No. 11.02.12).
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gürbüzel, M., Karaca, U. & Karayilan, N. Genotoxic evaluation of bupivacaine and levobupivacaine in the Drosophila wing spot test. Cytotechnology 68, 979–986 (2016). https://doi.org/10.1007/s10616-015-9852-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10616-015-9852-2